AzTrials
AzTrials

Intrusive Memories of Traumatic Event(s)NCT05089058

Lóa Project: An Exploratory Pilot Randomised Controlled Trial of a Remotely-delivered Brief Cognitive Intervention to Reduce Intrusive Memories of Trauma for Women in Iceland

A study testing Brief, digitally delivered imagery-competing task intervention package, comprised of: and Brief, digitally delivered relaxation task intervention, comprised of: in people with Intrusive Memories of Traumatic Event(s), run by University of Iceland at 1 site in Iceland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Intrusive memories are sensory memories of a traumatic event(s) that spring to mind involuntarily, evoke strong emotions, and disrupt functioning in daily life. Previous research has demonstrated that a brief cognitive intervention can prevent the development of intrusive memories as well as reduce the number of… Read more about this study

Who is it for?
Ages 18 to 69 years, women onlyHealthy volunteers can take part
Conditions the study is for
Intrusive Memories of Traumatic Event(s)
What is being tested?
Brief, digitally delivered imagery-competing task intervention package, comprised of: and Brief, digitally delivered relaxation task intervention, comprised of:
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
13 participants
Where
1 siteIceland
Study dates
1 Nov 2021to 4 Nov 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 69 years
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Aged: 18-69 (at time of enrollment to cohort study)
  • Able to speak and read study materials in Icelandic or English
  • Willing to be contacted remotely and having access to a smartphone or computer
  • Experienced intrusive memories in past month (PCL-5 item 1 score is ≥ 2)
  • Experienced 2 or more intrusive memories of a traumatic event in the past week
  • Willing to monitor intrusive memories in everyday life
  • Willing and able to complete remote study sessions

Who cannot join

  • Suicide risk indicated in the initial assessment (response of 'nearly every day' to item 9 on PHQ-9) and by responses on MINI during follow-up telephone risk assessment

Trial locations and contacts

1 site in 1 country.

Iceland1 site
  • University of Iceland, Sæmundargata 12

    Reykjavik, 102

Other trials in Iceland

About this study

Intrusive memories are sensory memories of a traumatic event(s) that spring to mind involuntarily, evoke strong emotions, and disrupt functioning in daily life. Previous research has demonstrated that a brief cognitive intervention can prevent the development of intrusive memories as well as reduce the number of intrusive memories of long-standing trauma. Initial pilot work (using case studies) with women in Iceland indicates that the intervention is acceptable and feasible.

This exploratory pilot trial will compare remote delivery of the intervention (i.e. brief, digitally delivered imagery-competing task intervention, n = 12) to an attention-placebo control condition (i.e., brief, digitally delivered relaxation exercise task; n = 12). We will explore whether (relative to the control condition) the intervention: (i) reduces the number of intrusive memories (primary outcome), and (ii) improves other symptoms and functioning.

This study is funded by the OAK foundation (OCAY-18-442) and the Strategic Research and Development Program: Societal Challenges in Iceland (200095-5601).

Read the detailed description

The proposed study will involve a brief intervention (c. 2 guided sessions with the researcher; options for up to 6 additional booster sessions) delivered digitally and remotely (i.e., not physically in-person), and with initial guided support (remotely delivered) from a researcher. Participants will be asked to fill out a diary indicating the number of intrusive memories they experienced, along with self-report questionnaires, at baseline (i.e., one week prior to commencement of the intervention), week 1 (week after the second intervention/control session), week 5 (primary outcome; 5 weeks from the second intervention/control session), and at 1-, 3- and 6-months follow-up.

Monitoring will be performed by a clinical trial unit to verify that the study is conducted and data are generated and documented in compliance with GCP and the applicable regulatory requirements.

Potentially eligible participants for this pilot study will be identified using data collected in the SAGA cohort study (an epidemiological study of trauma among Icelandic women).

Being tested
Brief, digitally delivered imagery-competing task intervention package, comprised of:, Brief, digitally delivered relaxation task intervention, comprised of:

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Brief, digitally delivered imagery-competing task intervention package, comprised of:Behavioural

    Two sessions guided (remotely) by a researcher. Sessions comprised of:

    (i) task procedure: a memory cue followed by playing imagery-competing computer game task with mental rotation instructions. Monitoring of intrusive memories to select hotspot cue, and which intrusion to target.

    (ii) accompanying information, including rationale for the brief cognitive task.

    (iii) option to use the brief cognitive task after the session (self-administered); option to engage in up to 6 guided booster sessions supported by a researcher.

  • Brief, digitally delivered relaxation task intervention, comprised of:Behavioural

    Brief, digitally delivered relaxation task intervention, comprised of:

    Two sessions guided (remotely) by a researcher. Sessions comprised of:

    (i) relaxation exercise task using instruction components from progressive muscle relaxation

    (ii) accompanying information, including rationale for the brief relaxation exercise task.

    (iii) option to use the brief relaxation exercise task after the session (self-administered); option to engage in up to 6 guided booster sessions supported by a researcher.

Study groups in NCT05089058
Study groupRoleWhat they receive
Brief cognitive task (delivered digitally)ExperimentalNot described
Receives: Behavioral: Brief, digitally delivered imagery-competing task intervention package, comprised of:
Brief relaxation exercise task (delivered digitally)Placebo comparatorNot described
Receives: Behavioral: Brief, digitally delivered relaxation task intervention, comprised of:

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of intrusive memories of traumatic event(s)

    Number of intrusive memories of traumatic event(s) recorded in a brief daily diary for 7 days

    Measured: Week 5

Secondary outcomes (15)
  1. Number of intrusive memories of traumatic event(s)

    Number of intrusive memories of traumatic event(s) recorded in a brief daily diary for 7 days

    Measured: Baseline, Week 1, Week 12 and Week 24

  2. The Posttraumatic Stress Disorder Checklist 5 (PCL-5)

    A 20-item questionnaire assessing the severity of PTSD symptoms corresponding to the DSM-5 criteria for PTSD. Symptoms are rated on a 5-point Likert-scale.

    Measured: Baseline, Week 1, and 1-month, 3-month and 6-month follow-ups

  3. The Patient Health Questionnaire-9 (PHQ-9)

    A 9-item questionnaire assessing depression symptoms and their severity. Items are scored from 0 (i.e., not at all) to 3 (i.e., nearly every day).

    Measured: Baseline, Week 1, and 1-month, 3-month and 6-month follow-ups

  4. The Generalized Anxiety Disorder-7 scale (GAD-7)

    A 7-item questionnaire designed as a screening tool for symptoms of GAD and their severity. Items are scored from 0 (i.e., not at all) to 3 (i.e., nearly every day).

    Measured: Baseline, Week 1, and 1-month, 3-month and 6-month follow-ups

  5. Characteristics of intrusive memories

    6 self-rated items assessing the frequency of unwanted memories of the trauma in the previous week (on a 7-point scale, from never to many times a day) and the level of distress, nowness, reliving, disconnectedness and whether different triggers are associated with unwanted trauma memories (on an 11-point scale, from 0 to 100). Higher scores indicate more unwanted memories, higher levels of distress/nowness/reliving/disconnectedness and more different triggers.

    Measured: Baseline, Week 1, and 1-month, 3-month and 6-month follow-ups

  6. Impact of intrusive memories on concentration, sleep and stress

    Assessed with six self-rated items anchored to the past week: two items assessing concentration difficulties in general and due to intrusive memories (11-point scale; high scores indicating more difficulties), one item assessing duration of disruption after experiencing intrusive memory (<1 minute to > 60 minutes), two items assessing sleep disturbance due to intrusive memories (11-point scale; higher scores indicating more sleep disturbance) and one item assessing the degree to which intrusive memories affected stress levels (0 = not at all; 10 = very much).

    Measured: Baseline, Week 1, and 1-month, 3-month and 6-month follow-ups

  7. General impact of intrusive memories

    Assessed with two self-rated items, one assessing the degree of distress associated with intrusive memories and the other assessing how vivid they were in the past week (both rated on an 11-point scale, 0 = not at all; 10 = very distressing; 0 = not at all; 10 = very vivid).

    Measured: Baseline, Week 1, Week, 5, Week 12 and Week 24

  8. Impact of intrusive memories on daily functioning

    Assessed with four items. One question is self-rated: "Have the intrusive memories affected your ability to function in your daily life?" on an 11-point scale; higher score indicating greater impact on functioning. The other question is open-ended: "How have the intrusive memories affected your ability to function in your daily life in the past week?"). We will also explore whether there is a link between the content of participants' intrusive memories and specific domains of functioning - in open-ended discussion and using questions (asked at baseline) such as: "Are there any specific activities that you would like to do, but avoid because they are linked to your intrusive memories?" and "What change in your intrusive memories would make a meaningful difference in your life?" along with (asked at follow-ups, after the intervention/control task) "Since starting the study, are there any specific activities that you used to avoid (due to your intrusive memories), but now do more often?"

    Measured: Baseline, Week 1, and 1-month, 3-month and 6-month follow-ups

  9. The Sheehan Disability Scale (SDS)

    A self-report questionnaire assessing functional impairment across three domains: (1) Work/school, (2) social, and (3) family life. Domains are measured on an 11-point Likert scale, ranging from 0 (i.e., not at all) to 10 (i.e., extremely). The scale will be adapted to assess functional impairment associated with intrusive memories.

    Measured: Baseline, Week 1, and 1-month, 3-month and 6-month follow-ups

  10. The World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0)

    A 12-item questionnaire assessing difficulties due to health conditions, including mental or emotional problems (with reference to study event). Scores range from 1 ("none") to 5 ("extremely/cannot do"). Lower scores indicate better functioning.

    Measured: Baseline, Week 1, and 1-month, 3-month and 6-month follow-ups

  11. The Psychological Outcome Profiles; PSYCHLOPS

    A 4-item a patient-generated outcome measure of symptom-change after therapy/interventions, consisting of four items measuring three domains: problems (two items), function (one item), and well-being (one item). The patient chooses which symptoms or problems are most important to measure over the course of an intervention.

    Measured: Baseline, Week 1, and 1-month, 3-month and 6-month follow-ups

  12. Self-rated Health rating (SRHR)

    A single item assessing perceived health status on a 4-point scale (very good to very bad). The scale is reverse-scored; higher scores indicate better health.

    Measured: Baseline, Week 1, and 1-month, 3-month and 6-month follow-ups

  13. The Pittsburgh Sleep Quality Index Addendum for PTSD (PSQI-A)

    A 7-item self-report questionnaire assessing the frequency of disruptive nocturnal behaviours (e.g., acting out dreams, episodes of terror or screaming) common in PTSD. Respondents report symptoms over the past month on a 4-point Likert scale, ranging from 0 (never in the past month) to 3 (three or more times each week). Total score ranges from 0 to 21. A clinical score ≥ 4 will be used, which discriminates between participants with and without PTSD.

    Measured: Baseline, Week 1, and 1-month, 3-month and 6-month follow-ups

  14. Sleep Condition Indicator (SCI-2)

    2 self-rated items; one assesses the extent to which the respondent is experiencing poor sleep (with reference to study event) on a 5-point scale (from not at all to very much), one assesses the number of nights in the week the respondent experiences sleep problems on 5-point scale (from 0-1 to 5-7 nights). Both 5-point scales are reverse scored (0 - 4) then summed. Possible total scores range from 0-8; higher values indicate better sleep.

    Measured: Baseline, Week 1, and 1-month, 3-month and 6-month follow-ups

  15. Time Perspective Questionnaire (TPQ)

    8-items drawn or modified from both the Temporal Orientation Scale and the Zimbardo Time Perspective Inventory. Respondents rate how true statements are for them on a 5-point scale, from not at all true (1) to very true (5) (e.g., "My plans about the future are pretty well laid out", "It is best to live day-to-day").

    Measured: Baseline, Week 1, and 1-month, 3-month and 6-month follow-ups

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Oct 2021
  2. Study start1 Nov 2021
  3. Primary completion23 Jun 2022
  4. Study completion4 Nov 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
13 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05089058
Sponsor's protocol ID
20-214
Status last verified
Nov 2022
First submitted
5 Oct 2021
Last updated
17 Nov 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes

Questions about this trial

What is this clinical trial studying?

A study testing Brief, digitally delivered imagery-competing task intervention package, comprised of: and Brief, digitally delivered relaxation task intervention, comprised of: in people with Intrusive Memories of Traumatic Event(s), run by University of Iceland at 1 site in Iceland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Nov 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Iceland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of intrusive memories of traumatic event(s) (time frame: Week 5). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Nov 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in